VOLITIONRX LTD
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.7M | $1.2M | $775,302 | $306,392 | $90,035 |
| Research and development | $10.1M | $14.4M | $19.6M | $15.3M | $13.0M |
| Operating expenses | $23.5M | $28.3M | $36.8M | $32.1M | $28.4M |
| Operating income | -$21.7M | -$27.0M | -$36.0M | -$31.8M | -$28.3M |
| Interest expense | — | — | — | — | $155,803 |
| Income tax expense | $19 | $0 | — | — | — |
| Net income | -$23.4M | -$27.0M | -$35.7M | -$30.6M | -$27.0M |
| Balance Sheet | |||||
| Cash and equivalents | $1.1M | $3.3M | $20.7M | $10.9M | $20.6M |
| Current assets | $2.1M | $4.1M | $21.9M | $12.2M | $22.0M |
| Total assets | $6.9M | $9.4M | $28.0M | $18.3M | $27.5M |
| Current liabilities | $12.2M | $7.8M | $8.9M | $17.4M | $6.5M |
| Total liabilities | $42.5M | $35.5M | $36.7M | $21.4M | $9.8M |
| Stockholders' equity | -$34.2M | -$24.9M | -$7.8M | -$2.6M | $17.7M |
| Cash Flow Statement | |||||
| Cash from operations | -$19.7M | -$25.9M | -$18.1M | -$15.3M | -$20.9M |
| Depreciation and amortization | $1.0M | $1.1M | $1.1M | $865,262 | $812,109 |
| Stock-based compensation | $1.7M | $1.3M | $2.3M | $3.1M | $2.5M |
| Capital expenditure | $89,558 | $277,499 | $1.1M | $1.6M | $973,559 |
| Free cash flow | -$19.8M | -$26.2M | -$19.1M | -$16.8M | -$21.8M |
| Share repurchases | — | $0 | $31,772 | $0 | — |
| Impairments | — | $0 | $0 | $0 | $0 |
Shares outstanding 8.3M · Free float 92.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.